BioCatalystWatch
NKTXWorkspace / NKTX / OverviewCompany library
Price
Market cap
Next catalystExpected 1H 2027NKX019 — Ntrust-2 · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

NKX019

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

NKX019

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

NKX019

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

NKX019

CD19

PreINDP1P2P3FilingApproved

History / paused

NKX019

CD19

PreINDP1P2P3FilingApproved

NKG2D ligands × NKG2D receptor

PreINDP1P2P3FilingApproved
NKX019

CD19

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NKTX SEC archive